These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24752253)

  • 21. Class 1 integrons contributes to antibiotic resistance among clinical isolates of Escherichia coli producing extended-spectrum beta-lactamases.
    Chen T; Feng Y; Yuan JL; Qi Y; Cao YX; Wu Y
    Indian J Med Microbiol; 2013; 31(4):385-9. PubMed ID: 24064647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community.
    Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
    Microb Pathog; 2013; 61-62():16-22. PubMed ID: 23643553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by
    Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Matar GM; Abou Fayad A; Sherri N; Dhar R; AlFouzan W; Yusef H; El Chaar M
    Infect Dis Obstet Gynecol; 2020; 2020():4190306. PubMed ID: 32327921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved Accuracy of Cefepime Susceptibility Testing for Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae with an On-Demand Digital Dispensing Method.
    Smith KP; Brennan-Krohn T; Weir S; Kirby JE
    J Clin Microbiol; 2017 Feb; 55(2):470-478. PubMed ID: 27903600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors for extended-spectrum β-lactamase- and AmpC-producing Escherichia coli in dairy farms.
    Gonggrijp MA; Santman-Berends IMGA; Heuvelink AE; Buter GJ; van Schaik G; Hage JJ; Lam TJGM
    J Dairy Sci; 2016 Nov; 99(11):9001-9013. PubMed ID: 27638264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase.
    Doi Y; Paterson DL; Adams-Haduch JM; Sidjabat HE; O'Keefe A; Endimiani A; Bonomo RA
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3159-61. PubMed ID: 19414578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
    Kristo I; Pitiriga V; Poulou A; Zarkotou O; Kimouli M; Pournaras S; Tsakris A
    Int J Antimicrob Agents; 2013 Apr; 41(4):383-7. PubMed ID: 23375981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial Resistance Pattern and Genetic Characteristics of ESBL and Carbapenemase-producing Escherichia coli at a Tertiary Care Hospital in Bangladesh.
    Khan ER; Paul SK; Kobayashi N; Khan TR; Rahman MH; Rahman MM
    Mymensingh Med J; 2020 Jan; 29(1):37-42. PubMed ID: 31915333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iodometric and Molecular Detection of ESBL Production Among Clinical Isolates of E. coli Fingerprinted by ERIC-PCR: The First Egyptian Report Declares the Emergence of E. coli O25b-ST131clone Harboring bla
    El-Badawy MF; Tawakol WM; Maghrabi IA; Mansy MS; Shohayeb MM; Ashour MS
    Microb Drug Resist; 2017 Sep; 23(6):703-717. PubMed ID: 28099061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of NDM metallo-β-lactamase among ESBL-producing Escherichia coli İsolates.
    Çetinkol Y; Sandalli C; Çalgin MK; Yildirim AA; Akyildiz E; Karaman E; Çiçek AÇ
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):131-141. PubMed ID: 28420242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients].
    Marković T; Jeinić L; Smitran A; Petković M
    Srp Arh Celok Lek; 2013; 141(11-12):775-9. PubMed ID: 24502096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and characterization of extended-spectrum β-lactamase-producing Escherichia coli from chicken production chains in Nigeria.
    Ojo OE; Schwarz S; Michael GB
    Vet Microbiol; 2016 Oct; 194():62-68. PubMed ID: 27157499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period.
    Kiiru J; Kariuki S; Goddeeris BM; Butaye P
    BMC Microbiol; 2012 Jul; 12():155. PubMed ID: 22838634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of blaTEM , blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India.
    Bora A; Hazarika NK; Shukla SK; Prasad KN; Sarma JB; Ahmed G
    Indian J Pathol Microbiol; 2014; 57(2):249-54. PubMed ID: 24943758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Genetic Relatedness of Extended Spectrum-β-Lactamase-Producing
    Umair M; Mohsin M; Ali Q; Qamar MU; Raza S; Ali A; Guenther S; Schierack P
    Microb Drug Resist; 2019 Nov; 25(9):1374-1381. PubMed ID: 31268408
    [No Abstract]   [Full Text] [Related]  

  • 39. High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
    Maciuca IE; Williams NJ; Tuchilus C; Dorneanu O; Guguianu E; Carp-Carare C; Rimbu C; Timofte D
    Microb Drug Resist; 2015 Dec; 21(6):651-62. PubMed ID: 25734920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.